Literature DB >> 20926573

Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Sabine Steidle1, Luis Martínez-Sobrido, Markus Mordstein, Stefan Lienenklaus, Adolfo García-Sastre, Peter Stäheli, Georg Kochs.   

Abstract

The nonstructural protein NS1 of influenza A virus counteracts the interferon (IFN) system and thereby promotes viral replication. NS1 has acquired different mechanisms to limit induction of IFN. It prevents double-stranded RNA (dsRNA) and RIG-I-mediated activation of interferon regulatory factor 3 (IRF3), and it blocks posttranscriptional processing of cellular mRNAs by binding to the cleavage and polyadenylation specificity factor (CPSF). Using a mouse-adapted A/PR/8/34 virus and reverse genetics to introduce specific mutations in NS1 which eliminate one or both functions, we determined the relative contributions of these two activities of NS1 to viral virulence in mice. We found that a functional RNA-binding motif was required for IFN suppression and virulence. Restoration of CPSF binding in the NS1 protein of wild-type A/PR/8/34 virus, which cannot bind CPSF due to mutations in the central binding motif at positions 103 and 106, resulted in enhanced virulence. Surprisingly, if CPSF binding was abolished by substituting glycine for arginine at position 184 in the classical NS1-CPSF binding motif, the mutant virus replicated much more slowly in mice, although the mutated NS1 protein continued to repress the IFN response very efficiently. Our results show that a functional RNA-binding motif is decisive for NS1 of A/PR/8/34 virus to suppress IFN induction. They further demonstrate that in addition to its contribution to CPSF binding, glycine 184 strongly influences viral virulence by an unknown mechanism which does not involve the IFN system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926573      PMCID: PMC3004359          DOI: 10.1128/JVI.00701-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes.

Authors:  Idoia Burgui; Tomás Aragón; Juan Ortín; Amelia Nieto
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

Review 3.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

4.  Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus.

Authors:  P Staeheli; O Haller; W Boll; J Lindenmann; C Weissmann
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

5.  Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.

Authors:  Benjamin G Hale; John Steel; Rafael A Medina; Balaji Manicassamy; Jianqiang Ye; Danielle Hickman; Rong Hai; Mirco Schmolke; Anice C Lowen; Daniel R Perez; Adolfo García-Sastre
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

6.  Two nuclear location signals in the influenza virus NS1 nonstructural protein.

Authors:  D Greenspan; P Palese; M Krystal
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

Authors:  Diana L Noah; Karen Y Twu; Robert M Krug
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

8.  Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice.

Authors:  P Staeheli; P Dreiding; O Haller; J Lindenmann
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein.

Authors:  Ana M Falcón; Rosa M Marión; Thomas Zürcher; Paulino Gómez; Agustín Portela; Amelia Nieto; Juan Ortín
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

View more
  40 in total

1.  Emergence of a C-terminal seven-amino-acid elongation of NS1 in around 1950 conferred a minor growth advantage to former seasonal influenza A viruses.

Authors:  Florens Lohrmann; Ronald Dijkman; Silke Stertz; Volker Thiel; Otto Haller; Peter Staeheli; Georg Kochs
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

2.  Evolution of an avian H5N1 influenza A virus escape mutant.

Authors:  Kamel M A Hassanin; Ahmed S Abdel-Moneim
Journal:  World J Virol       Date:  2013-11-12

3.  Fluorescence-Activated Cell Sorting-Based Analysis Reveals an Asymmetric Induction of Interferon-Stimulated Genes in Response to Seasonal Influenza A Virus.

Authors:  Jessica von Recum-Knepper; Anne Sadewasser; Viola K Weinheimer; Thorsten Wolff
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

4.  Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation.

Authors:  Rei-Lin Kuo; Li-Hsin Li; Sue-Jane Lin; Zong-Hua Li; Guang-Wu Chen; Cheng-Kai Chang; Yi-Ren Wang; Ee-Hong Tam; Yu-Nong Gong; Robert M Krug; Shin-Ru Shih
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  Influenza virus pathophysiology and brain invasion in mice with functional and dysfunctional Mx1 genes.

Authors:  Nicole R Hodgson; Stewart G Bohnet; Jeannine A Majde; James M Krueger
Journal:  Brain Behav Immun       Date:  2011-07-29       Impact factor: 7.217

6.  Arenavirus reverse genetics for vaccine development.

Authors:  Emilio Ortiz-Riaño; Benson Yee Hin Cheng; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

7.  Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression.

Authors:  Alan Belicha-Villanueva; Juan R Rodriguez-Madoz; Jad Maamary; Alina Baum; Dabeiba Bernal-Rubio; Maria Minguito de la Escalera; Ana Fernandez-Sesma; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

8.  Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.

Authors:  Hui Yang; Wendy Winkler; Xiaopeng Wu
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

9.  Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.

Authors:  Aitor Nogales; Steven F Baker; Emilio Ortiz-Riaño; Stephen Dewhurst; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Authors:  Steven F Baker; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.